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EXAMINING THE EVIDENCE FOR USE OF THE KETOGENIC DIET 
IN TREATING OBESITY AND TYPE 2 DIABETES 
 
JASON TRUONG 
 
ABSTRACT 
Interest in the ketogenic diet and its potential to treat obesity and type 2 diabetes 
has been steadily growing in recent years. With a very limited amount of calories 
coming from carbohydrates (typically < 50 gm/day), and the majority of calories 
coming from fat, this diet leads to a states of physiological ketosis, in which 
ketone bodies replace glucose as the primary source of energy. Early clinical 
trials found this to lead to a spontaneous reduction in calories consumed, and it 
has been suggested that a state of ketosis has appetite suppressing properties. 
There are a few studies evaluating self-reported decrease in hunger while 
consuming a ketogenic diet, as well as the changes in hormone levels associated 
with appetite, but this evidence is limited. The primary determinant of weight 
change is the difference between calories consumed and calories burned, 
however there is some suggestion that the macronutrient composition of the 
ketogenic diet may have a specific metabolic advantage for weight loss separate 
from the total number of calories in deficit. Multiple diet comparison studies have 
found the ketogenic diet to be effective for weight loss in the short term, 
particularly when compared to low fat diets. It is questionable whether the 
 vi
ketogenic diet is sustainable in the long term, particularly without frequent 
nutritional counseling and monitoring. Still, there is preliminary evidence that the 
ketogenic diet can lead not only to a large amount of weight loss, but may also 
be effective in treating and reversing type 2 diabetes. Clinical trials have shown 
decreases in HbA1c, fasting glucose, and reduction of antiglycemic medication 
requirements, though it is unclear if these effects are primarily due to weight loss 
itself, or the specific composition of the ketogenic diet. These benefits need to be 
weighed against the risks, and a common criticism is its high fat content which 
can adversely affect serum lipid levels and thus risk of cardiovascular disease. 
Consuming a ketogenic diet with a high intake of saturated fat has been found to 
increase LDL cholesterol, however this effect can be mitigated by favoring 
polyunsaturated or monounsaturated fats instead. While the above findings 
provide a preliminary understanding of the effects of the ketogenic diet, more 
research is needed to further elucidate the effectiveness and safety of the diet for 
treating obesity and type 2 diabetes.  
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 1 
INTRODUCTION 
 
As the epidemics of obesity and type 2 diabetes continue to worsen 
around the globe (Afshin 2017), a thorough evaluation of the evidence of the 
risks and benefits of popular diets becomes increasingly important over time. In 
recent years there has been a resurgence of interest in the ketogenic diet among 
healthcare professionals and in popular culture. Its pervasiveness in the public 
consciousness is often perpetuated by celebrity endorsements and online health 
gurus, however it has also caught the attention of researchers and nutritionists, 
even making it to the pages of the most highly respected medical journals. In 
January 2018, a JAMA article briefly discussed some of the potential therapeutic 
uses and adverse effects of the ketogenic diet in obesity and type 2 diabetes 
(Abbasi 2018). While it is clear further studies are required for a better 
understanding of the diet’s long term effects, there is still significant primary 
literature on the ketogenic diet which requires careful review.  
Much of the literature on this topic comes from clinical trials in which 
participants are put on a specific diet, and the subsequent effects on their health 
are measured, however creating well designed studies in this way comes with 
some challenges. Clinical trials held within an inpatient setting have the 
advantage of being able to strictly control and monitor the foods consumed by 
participants, whereas outpatient studies often rely on self-report and food 
journals from participants. On the other hand, results from outpatient studies 
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utilizing counseling from nutrionists on food choices are more likely to be 
generalizable, and these studies have an easier time acquiring large sample 
sizes. Many of the studies discussed here fall into one of these categories. 
After some background information on the ketogenic diet and 
physiological ketosis, this thesis will summarize the methods and findings of 
important clinical trials evaluating the benefits and disadvantages of the 
ketogenic diet for treating obesity and type 2 diabetes. In particular, the focus will 
be on what conclusions can be drawn from the primary literature on the 
ketogenic diet in regards to weight loss, appetite suppression, glycemic control, 
and changes in lipid profiles.  
 
Definition 
 The definition of the ketogenic diet (KD) has some slight variation from 
different sources, however it is commonly accepted that it should have a 
maximum of 20-50 grams/day of carbohydrates, or < 10% of daily calories from 
carbohydrates, which is sufficient to achieve a state of physiological ketosis for 
most people, the primary distinguishing feature of the KD (Feinman, 2015). The 
remaining calories are comprised of mostly fat, and adequate protein. There is 
typically a high ratio of fat to protein in these remaining calories, as an excess of 
amino acids can be used in gluconeogenesis, thus negating the ketotic state 
(Mcpherson 2011). However, there is considerably less consensus on an exact 
ratio.  
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 It is important to note that while there is some overlap between the Atkins 
diet and KD, there are some key differences. First, unlike the KD where a very 
low level of carbohydrates is maintained daily, the Atkins diet advises starting 
with a very low amount of carbohydrate (20 gm/day) in the 2-week induction 
phase, followed by a gradual increase of 5-10 gm/day of carbohydrates in the 
following weeks. Also, the Atkins diet, particularly in its original form, encourages 
eating a relatively high proportion of daily calories from protein, whereas the KD 
typically has a higher proportion of fat. Finally, while individuals on the Atkins diet 
may enter a ketotic state in the early phases, remaining in ketosis is not 
considered necessary for the diet’s ostensible benefits. Still, the induction stage 
of the Atkins diet can be considered ketogenic, as consuming such a small 
portion of daily calories from carbohydrates can lead to ketosis for most people 
within roughly 3 days (Harvey 2011).  
 One of the challenging aspects of analyzing the KD literature is in 
identifying which studies utilize diet interventions that fit the definition. Much of 
the research on low carbohydrate diets in the 1990’s and early 2000’s was 
focused on the Atkins diet due to its popularity in those years, and some 
investigators have classified certain diet protocols as ketogenic despite being 
much closer to Atkins. For example, an often cited meta-analysis comparing 
weight loss from KD vs. weight loss from low fat diets (Bueno 2013) actually 
includes some clinical trials where the carbohydrate consumption of the 
supposed KD group far exceeds a reasonable limit for ketosis for most people 
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(Foster 2003; Davis 2009). On the other hand, some studies using an Atkins-like 
diet protocol only mildly increased carbohydrate intake over time, and even at the 
peak remained below 50 gm/day, so can be reasonably classified as a KD 
(Westman 2002; Yancy 2004). For the purpose of this thesis, a diet intervention 
will be considered a KD if the majority of participants are found to have a 
measured ketonuria or ketonemia, or if the daily consumption of carbohydrates is 
restricted to the 50 gm/day threshold when ketone levels are not measured.  
  
Biochemistry and physiology of the ketogenic diet 
The hallmark of the KD is to achieve a state of physiological ketosis (a.k.a 
nutritional ketosis). By restricting carbohydrate intake to a very low level, over 
time the human body enters a physiological state mimicking starvation, causing 
the liver to produce ketone bodies as a source of energy rather than the 
preferred glucose. In a normal fed state, glycolysis leads to the production of 
acetyl-CoA, which reacts with oxaloacetate from the citric acid cycle. However, in 
the absence of sufficient glucose, oxaloacetate is preferentially utilized for 
gluconeogenesis (Harvey 2011). Also, prolonged starvation leads to increased 
lipolysis and beta oxidation of fatty acids, creating an excess of acetyl-CoA, 
exceeding the oxidative capacity of the citric acid cycle. The excess acetyl-CoA 
is subsequently utilized to produce ketone bodies in the liver, principally 
acetoacetate and 3-hydroxybutyrate (Mcpherson 2011).  
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Figure 1. Biochemical pathway of ketone body formation. In the presence of 
sufficient glucose, oxaloacetate reacts with acetyl-CoA to continue the citric acid 
cycle. Without sufficient oxaloacetate when it is shifted for gluconeogenesis, 
acetyl-CoA is instead used to create ketone bodies such as 3-hydroxybutyrate 
(Mcpherson 2011) 
 
 During prolonged starvation, within 3-4 days glycogen stores are depleted 
and ketone bodies become the primary source of fuel for skeletal muscle and 
other tissues (Koeppen 2008). The brain highly prefers glucose as its source or 
energy so it will continue to do so through the glucose provided by 
gluconeogenesis, but eventually after about 3 weeks the brain will utilize ketone 
bodies as its primary source of energy (Koeppen 2008). In normal healthy 
individuals there is a baseline level of ketone bodies in the blood, which is 
increased to > 0.5 mmol/L in physiological ketosis. Ketosis can be measured by a 
fingerstick ketone meter available for purchase by the general public, and also by 
urine dipsticks. It should be noted that the level of ketonemia induced by diet is 
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considerably lower than that found in diabetic ketoacidosis (> 5 mmol/L), which is 
a dangerous pathological state found primarily in type 1 diabetics with poor 
glucose control (Cahill 2006). Also, unlike in diabetic ketoacidosis, physiological 
ketosis is not accompanied by a significant drop in blood pH (Cahill 2006). 
 There are some commonly reported negative side effects experienced by 
those on the KD, especially in the first few weeks on the diet. These are 
collectively referred to as the “keto flu,” and include headache, dizziness, 
difficulty concentrating, constipation, fatigue, halitosis, and muscle cramps 
(Yancy 2004). Since these effects are typically worse in the first few weeks as 
the body adjusts to a ketotic state, it has been suggested that this may be a 
significant reason why some individuals have difficulty adhering to the diet 
(Johnston 2006). More severe adverse effects such as cardiac arrhythmia have 
been found, but this is much less common (Johnston 2006, Tay 2015). A 
commonly reported metabolic effect of the KD is its adverse effect on lipid 
profiles, which will be discussed in more depth later in this thesis.  
Due to its very high dietary fat content, the KD is contraindicated for 
individuals with fat metabolism disorders (Kalra 2017). Pyruvate carboxylase 
deficiency is another contraindication for the KD. This disorder leads to 
inadequate gluconeogenesis, which individuals on the KD rely on for euglycemia 
since dietary carbohydrate intake is severely restricted on the diet (Marin-
Valencia 2010). The KD is also not recommended to anyone with porphyria, 
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since adequate glucose intake prevents acute porphyria attacks by reducing 
release of heme precursors (Kossoff 2009). 
 
History 
Though fasting and starvation have been used for seizure therapy as far 
back as the work of Hippocrates, Dr. Russell Wilder of the Mayo Clinic is credited 
with coining the term for the KD, and for its first therapeutic implementation in 
1921. After the discovery by another physician that elevated levels of acetone 
and 3-hydroxybutyrate could be found in both starvation and in a diet with a very 
high ratio of fat to carbohydrates, Dr. Wilder ran the first trial of the KD to treat 
epileptic seizures (Wheless 2008). This was followed up the same year by his 
colleague Dr. Mynie Peterman who had success treating pediatric epilepsy 
patients with a KD, prior to the advent of antiepileptic medications. This classic 
KD devised by Dr. Peterman was composed of 10-15 gm/day of carbohydrates, 1 
gm of protein/kg of body weight, and the remaining calories in fat, which is similar 
to protocols used today as a treatment for refractory seizures in children 
(Wheless 2008).  
 As Phenytoin was discovered in 1938 and other antiepileptic drugs 
became available, the KD was used less often as a treatment (Wheless 
2008).  For several decades afterward there was a dearth of literature and 
interest the KD outside of its specific use for epilepsy. In the 1950’s to 1970’s the 
diet-heart hypothesis - which suggested a link between dietary fat, cholesterol 
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and cardiovascular disease - gained significant traction, and low fat eventually 
became the dietary zeitgeist for recommendations for public health by the U.S. 
government (Berge 2008). By 1984, the scientific consensus was that a low fat 
diet was recommended for all adults to lose weight and prevent heart disease, 
and 4 years later the U.S. Surgeon General warned about the dangers of dietary 
fat in “The Report on Nutrition and Health,” labeling fat as the unhealthiest aspect 
of one’s diet (Berge 2008). Clearly the KD, high in fat and low in carbohydrates, 
was anathema to recommendations of the time.  
 Today, this campaign to significantly reduce fat consumption is considered 
one of the greatest failures of public health policy. The steep rise in obesity rates 
and prevalence of type 2 diabetes coincides with the low fat era of the 1980’s 
and beyond (Feinman 2015). As it became understood that nutrition 
recommendations needed to be reevaluated, interest in low carbohydrate diets 
grew. Dr. Atkins released his second book in 1998 and by the early 2000’s he 
had become a household name (Berge 2008). The popularity of the Atkins diet 
has waned. However, over the last couple of years the interest in the ketogenic 
diet, endorsed by celebrities such as Halle Berry and proliferated on social 
media, has continued to rise as of the writing of this thesis.  
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Figure 2. Google trend of public interest in ketogenic diet. Google searches 
for “keto diet” have risen greatly since early 2017 and continues to grow. Y-axis 
in this chart indicates relative interest based on a 0-100 scale, with 100 indicating 
the highest popularity the search term has ever achieved. Taken from 
trends.google.com.  
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SPECIFIC AIMS 
 
The specific aims of this thesis are:  
1. Establish how weight loss is induced by diet, and to examine the evidence 
for the effectiveness of the ketogenic diet to treat obesity, particularly in 
comparison to other diets.  
2. Evaluate the evidence for the ketogenic diet’s ability to suppress appetite. 
3. Discuss the ability of diet modification to treat or reverse type 2 diabetes, 
and the effectiveness of the ketogenic diet in this regard. 
4. Provide background information on the relationships between dietary fat, 
serum lipid levels, and risk of heart disease, followed by an examination of 
the evidence for the ketogenic diet’s adverse effect on lipid profile. 
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WEIGHT LOSS 
 
Calories in, calories out 
There is a strong scientific consensus that the ultimate determinant of 
weight change is simply a thermodynamic calculation of energy balance, known 
colloquially as “calories in, calories out.” That is, when taking the number of 
calories consumed by an individual and subtracting the number of calories 
burned (energy expenditure) within a certain period of time, a positive number 
(caloric surplus) will lead to weight gain, a negative number (caloric deficit) will 
lead to weight loss, and zero difference means weight will not change (Buchholz 
2004). Based on research done in the 19th century using bomb calorimeters, the 
calculated values of calories from each of the macronutrients are still widely 
accepted today: carbohydrate provides 4 calories/gm, protein 4 calories/gm, and 
fat 9 calories/gm (Buchholz 2004). This principle of energy balance is consistent 
in the weight loss found in studies comparing two diets varying in composition of 
macronutrients but isocaloric in energy, including ones discussed in more detail 
later in this thesis (Gumbiner 1996; Johnston 2006; Brinkworth 2009; Tay 2015). 
In each of these studies, as expected there is no statistically significant difference 
in the amount of weight loss between the two diet groups.  
Though “calories in, calories out” is accurate from a thermodynamic 
perspective, for a more complete understanding of weight changes across 
populations, one must examine the choices people make in their diet. The 
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obesity rate continues to climb among US adults, reaching 40% according to a 
recent report by the CDC (Hales 2017), and many obese or overweight 
individuals have attempted one or more of the numerous fad diets promising 
quick and sustainable weight loss. A comprehensive meta-analysis published in 
2014 by Johnston et al. examined the relative amount of weight loss across 
multiple popular diets, which were divided into low carbohydrate (Atkins, Zone, 
South Beach), low fat (Ornish, Rosemary Conley), and moderate macronutrients 
(Weight Watchers, Nutrisystem, Jenny Craig, Biggest Loser, Volumetrics). 
Included in the meta-analysis were 48 randomized controlled trials and 7286 
subjects, most of whom were clinically obese. The authors found significant 
weight loss in all the different diets at the 6 month and 12 month marks 
compared to controls (no diet), with minimal differences between the different 
diet groups, or the individual diets themselves (Johnston 2014). As the meta-
analysis above showed only mild differences in weight loss between different 
diets, it appears that adherence is more important than the diet itself - whatever it 
takes to remain in a caloric deficit is key. While this meta-analysis does cover a 
significant number of popular diets, the KD was not specifically included in the 
low carbohydrate group.  
 
Is a calorie a calorie? 
Related to “calories in, calories out” is another concept known as “a 
calorie is a calorie,” meaning that each individual calorie consumed in one’s diet 
 13 
is equivalent in the thermodynamic calculation of body weight regardless of 
whether it comes from fat, protein, or carbohydrate (Buchholz 2004). Thus, one 
person’s weight should react the same to two different diets if they have the 
same amount of calories, regardless of the macronutrient composition. However, 
it has been suggested by some that a KD actually has a metabolic advantage 
over other diets of the same energy content (Paoli 2013) by increasing resting 
energy expenditure.  
One study challenging the idea that “a calorie is a calorie” was performed 
by Ebbeling et al., where 21 overweight and obese participants were given a 
restricted energy diet to induce 12.5% weight loss during a run-in (pre-test) 
phase. Each participant was then placed on 3 isocaloric diets during the test 
phase in a randomized crossover design during an inpatient stay lasting 4 weeks 
per diet, and tested the resting energy expenditure (REE) with indirect 
calorimetry during each diet. The macronutrient proportions in percent of daily 
calories (carbohydrate/ fat/ protein) were 60/20/20 for the low fat diet, 40/40/20 
for the low glycemic index diet, and 10/60/30 for the very low carbohydrate diet 
(VLCD). At 10% daily calories from carbohydrate (50.1 gm/day in this study), the 
VLCD is right at the borderline of being a KD. The investigators found that the 
VLCD group had the highest REE while the low fat diet group had the lowest 
(Ebbeling 2012).  
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Figure 3. Diet phases for Ebbeling et al. study. Following the run-in phase in 
which participants sustained a 12.5% weight loss, each subsequently went on 4 
weeks of each of the test diets described above, in randomized order. Taken 
from (Ebbeling et al. 2012) 
 
Another study also evaluating energy expenditure had 17 overweight or 
obese subjects eat 4 weeks of a baseline diet followed by 4 weeks of an 
isocaloric KD with < 31 gm of carbohydrates (Hall 2016). The participants 
remained in a metabolic ward where their energy expenditure was measured, 
and again during the KD they were found to have a slightly higher REE. Long 
term weight loss is often complicated by decreases in energy expenditure and 
increase in hunger (Leibel 1995), so these findings suggest that the 
macronutrient composition of the KD may be favorable for preventing weight 
regain.  
 
Early ketogenic clinical trials  
The first study utilizing a ketogenic KD for weight loss that was led by Dr. 
Eric Westman, one of the staunchest proponents of a very low carbohydrate diet, 
was published in 2002. Over the course of 6 months, 51 obese subjects were 
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placed on what was labeled a “ketogenic low calorie diet,” which consisted of < 
25 gm carbohydrates a day. The participants received regular counseling on food 
choices throughout the study, and were encouraged to eat until no longer hungry. 
Urinary ketones were measured to evaluate adherence to the diet and all 41 of 
the subjects that completed the study were found to have ketonuria. Despite the 
lack of instruction on calorie restriction, subjects on average lost 7.7 kg of body 
weight over the course of 6 months (Westman 2002).  
A subsequent study with a similar diet protocol was published by Boden 
et. al in 2005, in which 10 type 2 diabetic subjects who volunteered to participate 
in this 3-week study. Unlike the one by Westman et al, this was performed in an 
inpatient setting, so all food and drink consumed was weighed and recorded. In 
the first week the subjects ate their usual diets, and in the following two weeks 
they were restricted to < 21 gm of carbohydrates daily, however were not 
restricted in the amount of protein and fat they could consume. Urine tests 
revealed that they had elevated ketone levels throughout the latter 2 weeks, 
indicating a state of nutritional ketosis. While weight remained at baseline in the 
first week, there was a statistically significant weight loss in the second and third 
weeks, which corresponded to the spontaneous drop of calorie consumption. 
Mean calories consumed per day dropped from 3111 cal/day to 2164 cal/day 
over the two ketogenic weeks, accounting for the mean weight loss of 1.65 kg 
(Boden 2005).   
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Though there were clinical trials that had been done using low 
carbohydrate diets previously, those were primarily modeled after the Atkins diet. 
These aforementioned studies are among some of the most cited in the literature 
on the KD for weight loss, and have been instrumental in generating interest for 
further research. Their results included a considerable rate of weight loss, 
despite letting subjects freely choose the amount of food consumed, outside of 
the carbohydrate restriction. Other favorable effects were noted as well. In the 
study by Westman et al. there were statistically significant decreases in total 
serum cholesterol and in blood pressure. During the ketogenic phase of the study 
by Boden et al., HbA1c, triglyceride levels, and total cholesterol levels had 
statistically significant decreases as well. However, the authors in both studies 
recognize that one of the important limitations was the lack of a strict control 
group or comparison to another kind of diet (Westman 2002; Boden 2005). 
Without a proper comparison diet, it is unclear whether the favorable effects were 
specifically due to the KD, or to weight loss alone. As mentioned before, purely 
from a weight loss perspective it appears that a long term caloric deficit is more 
important than which particular diet is used to accomplish this. While this 
preliminary evidence was promising, other studies were needed to elucidate the 
value of the KD by comparing it to other diets.  
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Comparisons to other diets 
 Most of the evidence in the literature for the benefits of a KD over other 
diets comes from studies directly comparing it to low fat diets. In these diets fat 
makes up a relatively low proportion of the calories consumed, with the majority 
of calories coming from carbohydrates. Examples of this include the Ornish diet 
and the diet approach recommended by USDA in the food pyramid introduced in 
1992. One example of this kind of diet comparison trial was conducted by Yancy 
et al. in an outpatient setting, in which 120 obese participants were randomized 
to one of two diets for 6 months: a KD of < 40 gm/day of daily carbohydrates 
without caloric restriction, or a low fat diet of < 30% of total daily calories from fat 
with instructions for at least a 500 calorie deficit (Yancy 2004). Participants in the 
KD diet group were largely found to have ketonuria throughout the study as 
expected, and their fat to protein ratio was high (68% vs. 26% of daily calories). 
The proportion of carbohydrates differed between the two diets by a ratio of 8% 
to 52% of daily calories. The results showed a significantly greater amount of 
weight loss in the KD group compared to the low fat group (12.0 kg vs 6.5 kg) as 
well as a higher rate of adherence - 76% of the KD participants and 57% of the 
low fat participants completed the 6-month study (Yancy 2004).  
Of particular importance is that despite the lack of explicit counseling on 
maintaining a caloric deficit, participants in the low carbohydrate group managed 
to lose more weight than those on the low fat diet who did have this counseling. 
This suggests that individuals on a KD will spontaneously reduce their calories 
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consumed, enough to maintain a significant negative energy balance. Numerous 
other studies that also compared a KD without calorie restriction vs. a low fat diet 
with calorie reduction instructions show similar results (Brehm 2003; Westman 
2008; Hussain 2012; Bazzano 2014; Goday 2016; Saslow 2017). Though there 
are meta-analyses comparing the weight loss of very low carbohydrate diets with 
low fat diets (Nordmann 2006; Bueno 2013), they also include studies with 
interventions that are not consistent with the aforementioned definition of a KD, 
and are actually closer to the Atkins diet by design (Foster 2003; Shai 2008; 
Davis 2009). Regardless, there is a multitude of individual diet comparison trials 
that appear to favor the KD for weight loss.  
Not all diet comparison trials found the KD to have an advantage for 
weight loss, however. Iqbal et al. noted that two important limitations that many of 
the clinical trials mentioned so far have in common are their relatively short 
duration, and their reliance of high-intensity lifestyle interventions. The durations 
range from as short as 3 weeks to a maximum of 1 year. Inpatient trials are of the 
highest intensity interventions since each meal could be provided and tracked, 
but even the outpatient ones involved weekly or biweekly group meetings for 
nutrition counseling, which may be impractical in a typical outpatient setting 
(Iqbal 2010). This group ran a clinical trial to test if they could reproduce these 
findings but over a longer period of time (2 years) and with a lower intensity 
intervention. Using a similar diet comparison (< 30 gm/ day of carbohydrates vs. 
low fat with a 500 calorie deficit), the authors compared weight loss and other 
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metabolic parameters between the two groups with a lifestyle intervention 
protocol involving weekly meetings only for the first month, after which 
participants only attended sessions once every 4 weeks.  
Their results differed drastically from the studies favoring the KD. 
Adherence throughout the study was poor - there was significant attrition through 
the 6, 12, and 24 month checkpoints, with only 68 of the original 144 participants 
returning for the assessment visit at the end of the trial. At each checkpoint both 
groups were found to have lost modest amounts of weight from baseline (at best 
-2.8 kg at 6 months), and there was no significant difference in amount of weight 
lost between the groups. Based on self-reported dietary intake, the participants 
did not appropriately restrict their carbohydrate consumption. The authors 
concluded that lower intensity lifestyle intervention is inadequate to sustain these 
diets, and that high intensity intervention was required (Iqbal 2010).  
 
Discussion 
 To lose weight, one must consume less energy than the body expends 
(Buchholz 2004). While this idea is relatively simple and uncontroversial, how this 
is best achieved is subject to much debate. There is strong evidence that the KD 
can be used as an effective tool for weight loss in those who are overweight or 
obese, as a multitude of clinical trials have shown. The lengths of most of these 
studies have been relatively short, ranging from 3 weeks to 6 months, so it is 
questionable whether their results are applicable for long term weight loss. While 
the results of diet comparison studies have often favored the KD for weight loss, 
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it is noteworthy that these are predominantly in comparison to low fat diets, likely 
because it was in line with dietary recommendations from health agencies from 
the 1980’s and 1990’s (Berge 2004). Demonizing fat and suggesting that it be 
replaced with carbohydrates has failed to prevent (and has likely been a direct 
contributor to) the rising rates of obesity and type 2 diabetes over the last few 
decades (Feinman 2015), thus making the low fat diet an easy target for 
comparison. The USDA has since revised its recommendations for a more 
moderate approach, however without specific macronutrient compositions. Other 
less controversial diets that have been shown to be effective for weight loss 
include the DASH diet and the Mediterranean diet (Estruch 2016; Soltani 2016), 
however there is a lack of literature on direct comparisons of the KD with them. 
  Following just about any of the numerous fad diets can lead to weight loss 
in the short term (Johnston 2014), however long term sustainability is more 
difficult. While studies that found the KD to be effective for weight loss were 
accompanied by frequent meetings with a dietary consultant or physician, it may 
be difficult to sustain in everyday practice, likely due to how restrictive the diet is 
in food choices (Iqbal 2010). There does not appear to be a “one diet fits all,” as 
diet should be tailored to individual preferences to promote adherence, 
particularly over the long term to prevent weight regain. The KD may be 
considered another option for those who have struggled to lose weight but have 
failed other diets.  
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There is also some evidence to suggest that the KD may have a metabolic 
advantage for weight loss due to increased resting energy expenditure when 
compared to a low fat diet (Ebbeling 2012; Hall 2016). In essence, a diet with a 
favorable macronutrient composition in itself is able to increase the “calories out” 
even if the number of “calories in” is the same as a diet with a different 
macronutrient composition. One possible explanation is that in a state of ketosis, 
gluconeogenesis from amino acids is required to maintain euglycemia, which is 
an energy expensive process (Paoli 2013). Regardless, in these studies on 
energy expenditure the authors recognize that the overall effect was very small, 
even “near the limits of detection with state-of-the-art technology” (Hall 2016). 
Also, in both inpatient and outpatient comparison studies, there has consistently 
not been a statistically significant difference in weight loss between isocaloric 
diets (Gumbiner 1996; Johnston 2006; Brinkworth 2009; Tay 2015). Rather than 
macronutrient composition, total calories consumed appears to be the dominant 
factor.  
Macronutrient composition can have other effects relevant for weight loss. 
There is evidence that diets high in refined carbohydrates have numerous 
detrimental metabolic effects, including elevated insulin release, increased 
hunger, and increased fat storage (Lennerz 2013). High intake of refined 
carbohydrates can lead to rapid weight gain, a common criticism of low fat diets 
(Feinman 2015). Thus “a calorie is a calorie” may not be entirely accurate when 
considering the overall effects of different macronutrients on the body. 
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APPETITE 
 
Measuring hunger and satiety 
Decreased appetite is one of the most common effects of the KD 
anecdotally reported by practitioners of the diet and the clinicians promoting it. 
However, unlike other easily quantifiable parameters such as weight, glycemia, 
or lipid profiles, there is some debate over the validity of systems used to 
measure subjective sensations of satiety or hunger. One of the most commonly 
used is a visual analog scale (VAS), where an individual is presented with a 
horizontal line (often 100 mm long) representing a spectrum with each endpoint 
of the line representing an extreme of hunger or satiety (Parker 2004). The 
individual is then asked to mark where they currently land on the scale based on 
how they feel. While classically done on paper, an electronic version is 
sometimes used as well (Almiron 2009).  
 
 
Figure 4. VAS for hunger. Example of a VAS line, where a subject can mark 
their current level of hunger with a pen. 
 
Reviews have shown that the VAS has some correlation with energy 
intake however is not a reliable predictor of the amount consumed across 
 23 
different subjects (Parker 2004). It appears to be most valid in predicting meal 
initiation and have some reliability for energy intake within individuals. This 
suggests that the VAS is best used for repeated-measures designs such as a 
crossover study, where each participant will undergo more than one treatment (or 
diet) protocol (Stubbs 2000). Another concern is that the VAS line does not 
necessarily have the mathematical properties of a true ratio scale: the difference 
between marking 60 mm and 70 mm on a 100 mm VAS may not be the same as 
the difference between 20 mm and 30 mm (Blundell 2010).  
 A meta-analysis was performed by Gibson et al. to evaluate the appetite 
of study participants in physiological ketosis based on VAS scores. This meta-
analysis included 12 studies where participants underwent a diet induced ketosis, 
specifically those which included a within-subject repeated-measure VAS scores 
of satiety since the was previously shown to be more valid and reliable than 
between-subject comparisons (Stubbs 2000). Two different diets types were 
included in this study: a “ketogenic low carbohydrate diet” (KLCD) was defined as 
a maximum of 50 gm of carbohydrate with unrestricted protein and fat 
consumption; and the other was a “very low energy diet” (VLED) with similar 
maximum amount of carbohydrate, however was also restricted in calories to 800 
calories/day. They found that overall there was a statistically significant decrease 
in sensation of hunger and increase in satiety for these subjects. Though the 
effect size was small - 6.5 mm on the 100 mm VAS line for the VLED, and 5.5 
mm for the KLCD - the authors note it is still remarkable that there is no increase 
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in hunger which one might expect from weight loss while eating at a caloric deficit 
(Gibson 2015). This suggests that a ketogenic diet may be able to prevent the 
regaining of weight from increased appetite that typically follows weight loss.  
 
Regulatory hormones 
While reports of satiety and hunger can suffer from subjective bias, levels 
of hormones that regulate appetite can be more objectively measured. 
Orexigenic (hunger inducing) hormones include ghrelin and neuropeptide Y, 
whereas anorexigenic (satiety inducing) hormones include cholecystokinin 
(CCK), glucagon-like peptide 1 (GLP-1), leptin, and amylin (Paoli 2015). One of 
the greatest challenges to sustained weight loss is the subsequent increase in 
appetite, causing many dieters to regain the weight they had lost. It is known that 
during periods of sustained weight loss, levels of orexigenic hormones increase 
while satiety hormone levels decrease, and that these changes persist over time 
(Sumithran 2011). 
 It has been suggested that physiological ketosis suppresses appetite by 
affecting the levels of these very hormones. A 10-week study was done by 
Sumithran et al. to test this hypothesis. The 39 overweight/ obese subjects who 
completed the study were provided low energy meal replacement shakes for all 
three meals daily for 8 weeks, followed by a 2-week period of gradual refeeding 
with regular foods. The refeeding period was meant to reverse ketosis by 
increasing the amount of carbohydrates consumed, during which the participants 
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remained in a caloric deficit. Hormone measurements were compared between 
baseline levels, levels at the end of the 8-week period and those at the 
subsequent 2 weeks. As expected, subjects were found to be in a state of ketosis 
at the 8-week mark as measured by the levels of the ketone body 3-
hydroxybutyrate, and this ketosis was suppressed during the refeeding phase 
with the increased consumption of carbohydrates. Reported hunger scores were 
lower at 8 weeks of ketosis compared to the end refeeding phase, consistent with 
prior studies with self-reported sensation of hunger and satiety (Sumithran 2013).  
This study had mixed results with some hormone levels changing in a 
direction suggestive of appetite suppression, while other hormones did not follow 
this trend. Levels of the orexigenic hormone ghrelin were suppressed during the 
ketotic phase, and rose significantly during the refeeding phase, suggesting a 
possible mechanism for appetite suppression while in ketosis. Additionally, levels 
of the satiety peptide CCK were reduced after the refeeding. However, levels of 
several satiety hormones either had no statistically significant difference (GLP-1) 
or were actually lower (leptin, amylin) during the ketotic phase compared to after 
refeeding, whereas one might expect these levels to increase with appetite 
suppression (Sumithran 2013). Since the relative potency of each of these 
hormones and the details of their interactions remain unclear, the author 
suggests it is possible that ghrelin was the dominant signal of appetite in this trial, 
but this is also unclear.  
 26 
Evidence from animal studies does not clarify how ketosis affects appetite 
regulating hormones. One example is that during the first days of ketosis, there is 
a rise in the blood concentration of adiponectin, a hormone released from 
adipose tissue that increases the breakdown of fatty acids as a source of energy 
(Paoli 2015). Adiponectin also has an effect of increasing activity of AMPK in the 
hypothalamus, and studies on mice have shown that increasing AMPK activity in 
the hypothalamus has the orexigenic effect of increasing food consumption 
(Zhang 2009). However, the ketone body 3-hydroxybutyrate has been shown to 
directly inhibit the activity of AMPK, which appears to have an anorexigenic effect 
of decreased food consumption (Cheng 2008; Zhang 2009). 
 
Discussion 
Proponents of the KD often suggest that the appetite reducing effect of 
ketosis explains the spontaneous reduction in calorie intake of participants on the 
KD in clinical trials (Gibson 2015). While decreased hunger is often reported in 
the literature, measuring a phenomenon that it both physiological and 
psychological is difficult. One challenge lies in the lack of consistency in the 
terminology for assessing appetite. Hunger and satiety may seem colloquially to 
be on opposite ends of the same spectrum, however it has been suggested that 
hunger, satiety, fullness, desire to eat, and prospective consumption are all 
distinct sensations that can be measured separately on VAS (Blundell 2010). 
These are terms that a study participant may have difficulty distinguishing the 
 27 
difference between and may have significant changes in meaning or connotation 
when translated to other languages (Gibson 2015).  
Measuring hormone levels may be less prone to subjective bias, however 
there is a relative lack of literature on the effect of the KD on orexigenic and 
anorexigenic hormones. There are considerably more studies focusing on weight 
loss and other metabolic parameters including glycemic control and lipid profiles. 
The study by Sumithran et al. provides some data to suggest that ketosis has 
appetite suppressing effects, but clearly more research is needed. This study 
lacks a strict control group, and by the authors’ own admission, hormone levels 
at the 2-week refeeding period is not ideal for comparison (Sumithran 2013). 
Furthermore, the results were mixed as not all hormone levels changed in a 
direction that would support the hypothesis that ketosis suppresses diet. The 
physiological mechanisms controlling appetite involve a complex network of 
hormones, and the specific effects of ketosis on this system are not well 
understood.  
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TYPE 2 DIABETES MANAGEMENT 
 
 
Diet modification  
Type 2 diabetes (T2D) is a chronic metabolic disorder characterized by 
hyperglycemia and insulin resistance. In a report by the American Diabetes 
Association (ADA), nutrition therapy is considered to be integral to T2D 
management. There is strong evidence for the clinical benefits of proper nutrition 
in improving glycemia, blood pressure, and blood lipid levels (Evert 2013). In fact, 
primary care-led weight management has been shown to be successful in the 
remission of T2D to a nondiabetic state no longer requiring antidiabetic 
medications for many people (Lean 2018). Nondiabetic individuals at high risk for 
developing the disease can also benefit - a large scale study by the Diabetes 
Prevention Program Research Group found that maintenance of 7% weight loss 
by dietary changes and physical exercise reduced incidence of diabetes by 58% 
compared to placebo (Diabetes 2002). Proper diet is clearly a key part in the 
treatment of T2D, however there is no clear consensus over the specifics. The 
ADA recommends that nutrition therapy be individualized to each patient, and 
that there is no ideal ratio of macronutrients for all who have the disease (Evert 
2013).  
There are some who believe the KD to be the most effective path to T2D 
remission. Virta Health, a clinic founded in 2014, provides nutritional and 
behavioral counseling using a telemedicine platform, with the goal of using the 
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KD to reverse T2D (Mckenzie 2017). The company is running an ongoing study 
on the progress of their patients, who are instructed to eat < 30 gm/day of 
carbohydrates, 1.5 gm of protein/ kg of bodyweight, and the remaining calories in 
fat. Biometrics are measured with tools including ketone meters and finger stick 
glucose machines, and this information is sent electronically to the physician or 
nurse practitioner supervising the patient, who provide regular counseling 
(Hallberg 2018).  
 
 
Figure 5. Virta Health app. Example of the smartphone app used by Virta 
Health for monitoring a patient’s progress. Taken from 
https://www.virtahealth.com/thevirtatreatment  
 
 30 
The study data at 1-year revealed decreases in HbA1c, weight, and need 
for diabetic medications, as well as increases in LDL and HDL cholesterol levels. 
Of course, as this study is funded and run by Virta Health with their own patients 
in a nonrandomized clinical trial (Hallberg 2018), the results should be interpreted 
with caution. Fortunately, there are multiple studies in the literature evaluating the 
effects of the KD on glycemic control. 
 
Glycemic control in ketogenic clinical trials 
One of the earliest clinical trials specifically investigating the metabolic 
effects of the KD on patients with T2D was conducted by Gumbiner et al. in 
1996. In this small crossover study, 13 obese subjects with T2D were split into 
two groups, 7 receiving a low calorie KD and 6 receiving a low calorie high 
carbohydrate diet for 3 weeks. All subjects were subsequently crossed over to 
consume the other diet for another 3 weeks. Due to careful caloric control in the 
meals provided to all subjects, as expected there was no significant difference in 
the weight loss amount in with either diet. However, this study was significant for 
finding that during the ketogenic phases for both subject groups, there was 
reduced hepatic glucose output, lower fasting blood glucose levels, and lower 
glycemia following an oral glucose tolerance test (Gumbiner 1996).   
Some studies have found similar results. In the 2005 study by Boden et 
al., HbA1c was found to decrease from a mean of 7.3% to 6.8%, and Insulin 
sensitivity improved by 75% within the short 2-week ketogenic period of the study 
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(Boden 2005). Another study was published the same year evaluating HbA1c as 
its primary outcome, and found a mean decrease from 7.8% to 6.3% in 28 T2D 
patients consuming a KD (Yancy 2005). However, these studies suffered from 
small sample sizes, short durations, and lack of a comparison with another diet. 
In diet comparison studies (primarily KD vs. low fat/high carbohydrate), results 
are mixed.  
Since weight loss itself is known to improve HbA1c and fasting glucose for 
obese individuals with T2D (Evert 2013), diet comparison studies are useful for 
comparing the relative amounts of reduction in these parameters. Some have 
found that the KD is superior (Yancy 2010; Hussain 2012; Goday 2016; Saslow 
2017), however others have found no statistical difference between the KD group 
and the comparison diet group (Daly 2006; Johnston 2006; Brinkworth 2009; 
Iqbal 2010; Tay 2015). Of note, in isocaloric diet comparison studies in which 
there was no significant differences in amounts of weight loss between 
comparison groups, the results often showed there was little to no specific 
advantage to the KD for glycemia (Johnston 2006; Brinkworth 2009; Tay 2015).  
A meta-analysis by Ajala et al. compared the effects of low carbohydrate 
diets, low glycemic index diets, the Mediterranean diet, and high protein diets, 
which included 3460 individuals with T2D across 20 randomized controlled trials. 
They found statistically significant weight loss and decrease in HbA1c in all these 
diet categories, with the greatest effect size in the Mediterranean diet studies 
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(Ajala 2013). The low carbohydrate category included not only the KD but also 
Atkins and other diets with a more moderate carbohydrate restriction.  
Insulin sensitivity is another important consideration for T2D. The study by 
Boden et al. in 2005 showed that the KD can reduce insulin resistance, however 
without a diet comparison group this may be primarily due to weight loss itself. 
The KD’s specific effect on insulin sensitivity independent of weight loss may be 
related to the types of fat consumed on the diet. There is evidence that when 
carbohydrate or saturated fat is replaced by monounsaturated or polyunsaturated 
fat in the diet, insulin sensitivity is improved (Lara-Castro 2004). This is one of 
the reported benefits of the Mediterranean Diet, which emphasizes unsaturated 
sources of fat (Esposito 2004). On the other hand, relatively high levels of dietary 
saturated fat can worsen insulin resistance (Lara-Castro 2004). Thus far the 
studies on the effect of types of fat on insulin sensitivity have typically utilized diet 
interventions without the extreme carbohydrate restriction or very high proportion 
of dietary fat in the KD. Further research is necessary to elucidate whether the 
KD can also lead to a similar improvement independent of weight loss.  
 
Discussion 
 Though it is recognized that the total intake of carbohydrates is the 
primary predictor of glycemic response after a meal, the ADA does not endorse 
the idea of a specific proportion of daily calories from carbohydrates to be applied 
broadly for those with T2D (Evert 2013). While some researchers suggest the KD 
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is the superior choice over other diets for those with T2D (Feinman 2015), the 
collective evidence in the literature does not appear to support this hypothesis. It 
is true many participants with T2D across multiple clinical trials have shown 
improvements in their glucose levels and HbA1c, but these effects have not been 
adequately shown to be independent of weight loss. In isocaloric diet comparison 
studies the KD generally did not improve HbA1c or glucose levels more than the 
low fat diet (Johnston 2006; Brinkworth 2009; Tay 2015). This suggests that in 
clinical trials where the KD had more favorable effects, greater weight loss itself 
was the likely cause. This is not to say that macronutrient composition is an 
irrelevant consideration for obese T2D individuals, but rather that weight loss is 
the dominant factor. It is noteworthy that in the study by Tay et al, participants in 
the KD group had a greater reduction in their need for antiglycemic medications 
compared to the LF group.  
 Thus, for an obese person with T2D, the superior choice for diet is 
whichever one they can adhere to for sustained weight loss. As discussed 
previously, the KD may work for some people to lose large amounts of weight, 
possibly due to the advantage of appetite suppression from ketosis (Gibson 
2015). However, because of its restrictive nature the KD may be difficult to 
adhere to over the long term, requiring frequent counseling and monitoring (Iqbal 
2010). The successful reversal of T2D by those utilizing Virta Health is likely due 
in large part to the clinic’s ability to provide this counseling and monitoring using 
a telemedicine system and a smartphone app for ease of tracking (Mckenzie 
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2017). As the Virta Health study does not have a comparison group also utilizing 
this technology (Hallberg 2018), it is unclear whether the KD is truly the best diet 
to be used in this situation, or whether similar success could be found using other 
diets with the same technology. 
Weight loss may not be a viable option for all type 2 diabetics however, as 
approximately 10% are not overweight nor obese (Puska 2013). Though some 
suggest that very low carbohydrate diets can be beneficial to these individuals 
(Feinman 2015), there is a lack of evidence in the literature to support the KD in 
this context, as the vast majority studies on the KD are in the setting of weight 
loss.   
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CHOLESTEROL AND TRIGLYCERIDES 
 
Diet-Heart Hypothesis 
While hyperlipidemia is well established as a significant risk factor for 
cardiovascular disease (CVD) (Nelson 2013), a group of diseases including 
stroke and coronary artery disease (CAD), there is some debate on the role of 
dietary fats. The diet-heart hypothesis suggests that consuming excess dietary 
fat (saturated fat in particular) leads to hyperlipidemia and subsequently 
increased risk of CAD, and therefore efforts should be made to reduce serum 
cholesterol levels (Weinberg 2004). Two major studies providing support for this 
hypothesis include the Seven Countries Study which showed correlational 
evidence of populations with diets high in saturated fat and their increased risk of 
cardiovascular disease, and the Lipid Research Clinics Coronary Primary 
Prevention Trial (LRC-CPPT) which showed that serum cholesterol reducing 
medication successfully lowered the risk of CAD (Pett 2017; The Lipid 1984). 
Though the LRC-CPPT was a drug trial rather than a diet trial, multiple health 
agencies including the National Institute of Health and the American Heart 
Association (AHA) nevertheless recommended low fat, high carbohydrate diets in 
the 1980’s in an effort to decrease cholesterol levels (Weinberg 2004). As 
previously mentioned, these dietary recommendations have largely failed as 
public health policy, and consequently the diet-heart hypothesis has been the 
subject of some criticism. The AHA has since revised its recommendations - in 
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their presidential advisory report from 2017, rather than keep total dietary fat low, 
the public is suggested to limit intake of saturated fat and replace it with 
unsaturated fat, especially polyunsaturated fat (Sacks 2017).  
There appears to be a strong causal relationship between saturated fat 
intake and serum cholesterol levels, as evidenced by a report published in 2016 
by the WHO (Mensink 2016). Many major health agencies including the WHO 
and AHA also agree on a direct link between dietary saturated fat and 
cardiovascular disease, however there is a growing dissidence to this idea. A 
2010 meta-analysis of 21 clinical trials involving nearly 350,000 subjects was 
performed by Siri-Tarino et al. to examine this possible link, and their results 
concluded that there was no association between saturated fat and CAD, stroke 
or CVD (Siri-Tarino 2010). Other meta-analyses have found similar results 
(Chowdhury 2014; Souza 2015). Still, those endorsing this contrasting view 
appears to be in the minority, and many have questioned the validity of the 
findings in these meta-analyses (Stamler 2010). Thus far, it appears that the 
evidence indicating dietary saturated fat increases CVD risk is stronger than the 
alternative hypothesis.  
 
Lipid profiles in ketogenic clinical trials 
 In the context of the KD, the large proportion of dietary fat intake is one of 
the most common criticisms of the diet. Fear of adverse effects on blood lipid 
levels, namely low density lipoprotein (LDL), high density lipoprotein (HDL), total 
 37 
cholesterol, and triglycerides is a significant reason the KD remains controversial 
(Bueno 2013). Since weight loss itself has been found to lower serum cholesterol 
levels, evaluating the specific effects of the KD on lipid profiles as compared to 
other diets is best done in isocaloric diet comparison studies.  
An outpatient clinical trial by Brinkworth et al. published in 2009 
randomized 118 obese individuals to either a low carbohydrate (LC) diet or an 
isocaloric low fat (LF) diet over 1 year. The LC diet remained at < 40 gm/day of 
carbohydrates, and participants in this group were found to have elevated blood 
levels of 3-hydroxybutyrate, so this diet protocol can be considered ketogenic. 
Saturated fat accounted for approximately 20% of total calories for both diets, 
considerably higher than most recommendations (Sacks 2017). Since the two 
diets were isocaloric, as expected there was no statistically significant difference 
in the weight loss between the two groups. Their findings included a greater 
increase of LDL cholesterol in the LC group (mean increase of 0.6 mmol/L vs. 0.1 
mmol/L), consistent with concerns about the KD’s negative effect on cholesterol 
levels. However, the authors also found an increase in HDL level and decrease 
in triglycerides, which is considered to be favorable in regards to CVD risk 
(Brinkworth 2009).   
Another group of researchers, recognizing the criticism of the KD in 
regards to its high fat content, examined the effects of a KD that favored 
polyunsaturated and monounsaturated fats. Tay et al. ran a year-long 
randomized clinical trial comparing the effects of a low carbohydrate diet (LC) 
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with a low fat/ high carbohydrate diet (LF) on 115 obese type 2 diabetic subjects, 
restricting saturated fat to < 10% of total calories for both diets (Tay 2015). In the 
LC, fat accounted for 58% of total daily calories. Participants in the LC group 
consumed < 50 gm/day of carbohydrates, and were found to have elevated blood 
levels of 3-hydroxybutyrate throughout the 12 months indicative of physiological 
ketosis. Again, no statistically significant difference in the amount of weight loss 
was found between the two groups. The results here differed from the trial by 
Brinkworth et al. in that participants in both diet groups were found to have 
reductions in LDL and total cholesterol. Similar to the prior study the subjects in 
the LC group here also had a greater increase in HDL cholesterol and greater 
decrease in triglycerides in comparison to the LF group (Tay 2015).  
 
 LC diet LF diet Diff. between 
groups 
P value 
Total Chol. 
mmol/L 
-0.1 (-0.3, 0.1) -0.2 (-0.4, 0.03) 0.1 (-0.2, 0.4) 0.76 
LDL Chol. 
mmol/L 
-0.1 (-0.3, 0.1) -0.1 (-0.3, 0.1) -0.02 (-0.3, 0.3) 0.97 
Table 1. Selected results from Tay et al. study. Results for changes in LDL 
and total cholesterol levels from baseline to end of the 52-week study, with 
confidence intervals in parentheses. Units are in mmol/L (multiply by 38.67 to 
convert to mg/dL). There were statistically significant reductions in total and LDL 
cholesterol levels for both the LC group and the LF group. There was no 
significant difference in the relative reduction between groups. Data taken from 
(Tay et. al 2015). 
 
Isocaloric diet comparison studies are in the minority, as there are 
considerably more studies comparing KD with low fat diets without isocaloric 
control. At least 2 meta-analyses of these trials reveal changes in lipid profiles 
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similar to the ones found in the study by Brinkworth et. al, namely the increase in 
both LDL and HDL, and decrease in triglycerides (Nordmann 2006; Bueno 2013). 
It is important to note however that a few of the trials included in these meta-
analyses utilize diet interventions inconsistent with the KD but are rather more 
Atkins-like in their eventual ramping up of carbohydrate intake well past 50 
gm/day (Foster 2003; Shai 2008; Davis 2009). Regardless, the fat content in the 
Atkins diet raises similar concerns about worsening of lipid profiles. Considering 
that the KD typically has an even higher proportion of fat, it is certainly possible 
that any effects on cholesterol and triglyceride levels due to the KD would be 
more pronounced than due to the Atkins diet.  
 
Discussion 
 Increasing serum levels of LDL and risk of CAD is a legitimate concern for 
anyone on a KD. Though there are some who question the connection between 
saturated fat and heart disease (Siri-Tarino 2010; Chowdhury 2014; Souza 
2015), the evidence does not appear robust enough to reject the idea that 
saturated fat should be limited. One of the weaknesses of the studies that favor 
this alternative hypothesis is that limiting saturated fat should not be considered 
independent of what replaces it in the diet (Stamler 2010). Reducing intake of 
saturated fat while increasing intake of carbohydrates (especially refined sugars) 
has not been shown to be beneficial for reducing risk of heart disease, whereas 
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replacing it with polyunsaturated or monounsaturated fat does appear to be 
beneficial in this regard (Sacks 2017).  
 Diet comparison studies involving the KD without caloric control have 
largely found that when lipid profiles were measured, participants on the KD 
tended to have increases in HDL and either an increase or no change in LDL 
levels (Yancy 2004; Nordmann 2006; Bueno 2013; Bazzano 2014). While some 
clinical trials found that individuals on the KD actually had decreases in LDL 
levels, these were associated with significant weight loss, and this improvement 
in LDL was not found to be independent of weight loss (Hussain 2012; Saslow 
2017). For an obese individual trying to lose weight, ideally one’s diet should lead 
to weight loss while improving metabolic parameters such as glycemic control 
and lipid profile, rather than worsening it. The collective evidence suggests that a 
KD can worsen cholesterol levels when saturated fat intake is not kept in check, 
however a KD that emphasizes unsaturated fat can avoid this issue (Tay 2015). 
Thus, any individual on this diet should be counseled on consuming foods high in 
polyunsaturated or monounsaturated fat. Restricting saturated fat to < 10% of 
total daily calories as it was in the Tay et al. study is in line with 
recommendations by the AHA (Sacks 2017). 
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CONCLUSION 
 
The KD can be an effective tool for treating obesity and T2D. Some 
studies have shown the KD can lead to weight loss, reduction of reliance on 
diabetic medications, and reversal of T2D, however the benefits of the diet 
lauded by its proponents may be a bit overstated. There is evidence to suggest 
that it is better than low fat diets for weight loss at least in the short term, but the 
low fat diet is no longer widely recommended. Further research is necessary to 
compare the KD with other diet plans, such as the USDA’s MyPlate or those with 
well-established benefits such as the DASH or Mediterranean diet. The KD may 
have an advantage in its appetite suppressing effect, which would be a 
reasonable explanation for the spontaneous reduction in calorie consumption in 
some clinical trials. However, the evidence for this effect of ketosis on hunger 
remains predominantly with anecdotal reports.  
The benefits of the KD also need to be weighed against the risks. It would 
be prudent for a dieter and their healthcare provider to closely monitor lipid 
profiles while on this diet. Proper counseling about the types of fats to be 
consumed in order to limit saturated fat intake is especially important for the KD 
considering that the majority of daily calories will come from fat. Fortunately, 
there is evidence that a KD comprised mostly of polyunsaturated and 
monounsaturated fat can lead to weight loss without increasing LDL and 
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triglyceride levels. In addition, some individuals may find the “keto flu” side 
effects of the diet to be intolerable, complicating long term adherence.  
Perhaps the most surprising conclusion to be drawn from the literature is 
that the KD does not appear to have a clear advantage for those with T2D. Using 
the KD to improve and even reverse T2D is certainly doable, particularly with a 
high intensity lifestyle intervention such as with Virta Health. It is understandable 
that these patients and their healthcare providers may feel that the KD is the 
answer that they have been searching for. Other organizations have been 
successful in T2D reversal and prevention using other diets, (Diabetes 2002; 
Lean 2018) and it is unclear whether a single diet can be considered the “best” 
choice to be applied broadly. Finding whichever diet plan works best for the 
individual’s needs for long term adherence is likely the better strategy. At the 
least, the current literature supports the idea that the KD should be considered as 
another viable option to treat obesity and T2D, and certainly further research on 
its risks and benefits is warranted.  
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